
ASTRO 2020: MFS Is a strong surrogate endpoint for OS for men receiving salvage RT for recurrent prostate cancer
An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving…
An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving…